Christopher Mason, PhD, is Tempus’ Vice President of Emerging Genome Technology. Dr. Mason has been a pioneer in next-generation sequencing (NGS) diagnostics, multi-omic approaches to modeling disease, and new biochemical and genomic methods. At Tempus, Dr. Mason is developing and advising on the cutting-edge technologies needed for NGS profiling, host responses to COVID-19, and computational … Continued
Ari Caroline is the Senior Vice President of Health Strategy at Tempus. Prior to Tempus, Ari was the CEO and Co-founder of Da’at AI, which he founded with Iker Huerga, Tempus’ Vice President of Data Engineering. At Da’at AI, Caroline created a clinical-first information and learning model that empowered longitudinal, outcome-based contracts between self-insured employers and … Continued
Andy Polovin serves as General Counsel at Tempus, where he oversees and is responsible for various legal and business issues. Prior to joining Tempus, Andy was the General Counsel of Uptake Technologies, Inc., a company specializing in Artificial Intelligence software for heavy industry. Andy has also served as an Assistant United States Attorney focusing on … Continued
Dr. Kim Blackwell serves as Tempus’ Chief Medical Officer. She joins Tempus from Eli Lilly, where she was Vice President of Early Phase Oncology and Immuno-oncology. Prior to that, she was a Professor of Medicine and Assistant Professor of Radiation Oncology at Duke University, where she directed the Women’s Cancer Program, Strategic Collaborations, and the … Continued
Lauren Silvis serves as Senior Vice President of External Affairs, overseeing regulatory, public policy and government affairs. Silvis most recently served as the Chief of Staff of the U.S. Food and Drug Administration. Prior to that role, she was the Deputy Center Director for Policy in FDA’s Center for Devices and Radiological Health. At the … Continued
Colette Freeman serves as Chief People Officer at Tempus. Colette is charged with shaping all strategic functions associated with the current and future employees of Tempus. Her focus will include leading initiatives centered around culture, recruiting, human resources and professional development. Colette has been curating nascent and mature organizations for the last twenty years. Prior … Continued
Dr. Joel Dudley serves as the Chief Scientific Officer at Tempus. Dr. Dudley was Associate Professor of Genetics and Genomic Sciences and founding Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. He also served as Executive Vice President for Precision Health for the Mount Sinai Health … Continued
Marc Yoskowitz serves as Chief Strategy Officer at Tempus. Prior to Tempus, Yoskowitz was Chief Business Officer, Pfizer Essential Health, leading a range of corporate initiatives and businesses within the Pfizer portfolio. Prior to Pfizer, he served as SVP, Strategy and Corporate Development at Hospira, where he led the company’s efforts in these areas and … Continued
Dr. Martin Stumpe serves as the Senior Vice President for Data Science at Tempus. Prior to joining Tempus, he founded and led the Cancer Pathology project at Google, which uses artificial intelligence to increase the accuracy in image-based cancer detection and grading. His team also succeeded in integrating these diagnostics into optical microscopy for real-time … Continued
Eric Singley serves as the Vice President of Product at Tempus. Prior to Tempus, he was head of product at Triggr Health, a company focused on individualized treatment for addiction recovery. Prior to Triggr Health, Eric spent 10 years at Yelp where he oversaw all of Yelp’s design and consumer-facing product teams, which included mobile, … Continued